Cabergoline and fibrosis Patient Reports February 12, 2012

Cabergoline Side Effects Report #4661108-9
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Male patient, 79 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: 0.5 MG (DAILY), ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, MADOPAR, SELEGILINE. Patient recovered.

Cabergoline Side Effects Report #4688270-6
Cabergoline side effect was reported by a Physician from on May 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, dyspnoea, fibrosis, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.

Cabergoline Side Effects Report #4742129-4
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on July 25, 2005. Male patient, 68 years of age, weighting 194.0 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, fibrosis, mitral valve disease, mitral valve incompetence. Cabergoline dosage: 6 MG (EVERY DAY), ORAL. During the same period patient was treated with GLUCOSAMINE, AMANTADINE. Patient recovered.

Cabergoline Side Effects Report #5014377-X
Cabergoline side effect was reported by a Physician from AUSTRALIA on May 16, 2006. Male patient, 65 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: fibrosis, heart valve replacement. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA. Patient recovered.


Cabergoline Side Effects Report #4638459-7
Cabergoline side effect was reported by a Physician from on Apr 04, 2005. Male patient, 58 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: fibrosis, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG 96 MG, INTERVAL: DAILY), ORAL. During the same period patient was treated with SINEMET, SELEGILINE HYDROCHLORIDE, SIMVASTATIN, TRANDOLAPRIL, RISPERDAL, AMIODARONE, FUROSEMIDE, CARVEDILOL. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #4562656-2
Cabergoline side effect was reported by a Physician from on Jan 14, 2005. Female patient, 56 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, fibrosis, mitral valve disease, tricuspid valve disease. Cabergoline dosage: 9 MG , ORAL. Patient recovered.

Cabergoline Side Effects Report #5161996-6
Cabergoline side effect was reported by a Physician from SPAIN on Nov 07, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.

Cabergoline Side Effects Report #4931009-7
Cabergoline side effect was reported by a Physician from SPAIN on Feb 14, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease , ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.

Cabergoline Side Effects Report #5603010-1
Cabergoline side effect was reported by a Physician from AUSTRALIA on Jan 15, 2008. Male patient, weighting 187.4 lb, was diagnosed with parkinson's disease , restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bronchial disorder, coronary artery bypass , dyspnoea exertional, fibrosis, lung consolidation, pleural effusion, restless legs syndrome. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, SINEMET CR, KARVEA, VITAMIN E, TRITACE, ZOCOR. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4966081-1
Cabergoline side effect was reported by a Physician from GERMANY on Mar 23, 2006. Female patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #4968257-6
Cabergoline side effect was reported by a Physician from GERMANY on Mar 23, 2006. Female patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #4984399-3
Cabergoline side effect was reported by a Physician from GERMANY on Apr 07, 2006. Female patient was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5083046-2
Cabergoline side effect was reported by a Physician from GERMANY on Aug 02, 2006. Male patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, fibrosis. Cabergoline dosage: unknown. Patient recovered.